A case of a 78-year-old man with transitional cell carcinoma and a paraneoplastic leukemoid reaction. The leukocytosis was present at the diagnosis of carcinoma. It dissipated with complete tumor resection, was absent when a surveillance computed tomography scan showed no evidence of recurrence at 6 months, and had returned with tumor recurrence at 8 months. This case demonstrates that a paraneoplastic leukemoid reaction can be used as a tumor marker in cases of transitional cell carcinoma when a leukemoid reaction is found at presentation.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.urology.2008.05.023 | DOI Listing |
Pediatr Int
December 2024
Division of Infectious Diseases, Department of Medical Subspecialties, National Center for Child Health and Development, Tokyo, Japan.
Background: Information on the etiology and prognosis for leukemoid reaction (LR) in children is still limited and little is known about the factors that distinguish LR from hematological malignancy (HM).
Methods: This was a single-center, case-control study. Pediatric patients (<18 years) with a white blood cell (WBC) count of 50,000/μL or more were included in the study.
Infect Drug Resist
November 2024
Department of Emergency, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, People's Republic of China.
Pathol Int
December 2024
Department of Obstetrics and Gynecology, Saiseikai Kawaguchi General Hospital, Kawaguchi, Japan.
Cureus
September 2024
Plastic Surgery, Dr. D. Y. Patil Medical College, Hospital & Research Centre, Dr. D. Y. Patil Vidyapeeth (Deemed to be University), Pune, IND.
In clinical practice, tetracycline antimicrobial agents often lead to adverse events with drug fever and leukemoid reaction (LR) being rare occurrences. Here, we present a case of tigecycline-induced LR in a burn patient, which we believe is the first reported case of tigecycline-induced drug fever and LR globally in a burn patient and second overall.
View Article and Find Full Text PDFGenes (Basel)
September 2024
Center of Pediatric Hematology Oncology, Azienda Policlinico di Catania, 95100 Catania, Italy.
Noonan syndrome (NS) is an autosomal dominant disorder that varies in severity and can involve multiple organ systems. In approximately 50% of cases, it is caused by missense mutations in the gene (12q24.13).
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!